Literature DB >> 24436550

Intra-arterial Stroke Management.

Ethan A Prince1, Sun Ho Ahn1, Gregory M Soares1.   

Abstract

Acute ischemic stroke is a leading cause of death and the leading cause of disability in the United States. Cerebral neuronal death begins within minutes after threshold values of blood oxygen saturation are crossed. Prompt restoration of oxygenated blood flow into ischemic tissue remains the common goal of reperfusion strategies. This article provides a brief overview of acute ischemic stroke, a summary of the major intra-arterial stroke therapy trials, and comments on current training requirements for the performance of intra-arterial therapies.

Entities:  

Keywords:  intervention; interventional radiology; ischemic stroke; thrombectomy; thrombolysis

Year:  2013        PMID: 24436550      PMCID: PMC3773040          DOI: 10.1055/s-0033-1353481

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  33 in total

Review 1.  Equipoise among recanalization strategies.

Authors:  T A Tomsick; P Khatri; T Jovin; B Demaerschalk; T Malisch; A Demchuk; M D Hill; E Jauch; J Spilker; J P Broderick
Journal:  Neurology       Date:  2010-03-30       Impact factor: 9.910

2.  A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).

Authors:  Henry Ma; Mark W Parsons; Soren Christensen; Bruce C V Campbell; Leonid Churilov; Alan Connelly; Bernard Yan; Chris Bladin; Than Phan; Alan P Barber; Stephen Read; Graeme J Hankey; Romesh Markus; Tissa Wijeratne; R Grimley; N Mahant; Tim Kleinig; John Sturm; A Lee; D Blacker; Richard Gerraty; M Krause; P M Desmond; S J McBride; Leanne Carey; David W Howells; C Y Hsu; Stephen M Davis; Geoffrey A Donnan
Journal:  Int J Stroke       Date:  2012-01       Impact factor: 5.266

3.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

4.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 5.  Basic neuroangiography: review of technique and perioperative patient care.

Authors:  Sun Ho Ahn; Ethan A Prince; Gregory J Dubel
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

6.  The burden and management of TIA and stroke in government-funded healthcare programs.

Authors:  Philip B Gorelick
Journal:  Am J Manag Care       Date:  2009-06       Impact factor: 2.229

7.  Alberta Stroke Program Early CT Scoring of CT perfusion in early stroke visualization and assessment.

Authors:  R I Aviv; J Mandelcorn; S Chakraborty; D Gladstone; S Malham; G Tomlinson; A J Fox; S Symons
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-05       Impact factor: 3.825

Review 8.  Intra-arterial stroke therapy: an assessment of demand and available work force.

Authors:  H J Cloft; A Rabinstein; G Lanzino; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

9.  A trial of imaging selection and endovascular treatment for ischemic stroke.

Authors:  Chelsea S Kidwell; Reza Jahan; Jeffrey Gornbein; Jeffry R Alger; Val Nenov; Zahra Ajani; Lei Feng; Brett C Meyer; Scott Olson; Lee H Schwamm; Albert J Yoo; Randolph S Marshall; Philip M Meyers; Dileep R Yavagal; Max Wintermark; Judy Guzy; Sidney Starkman; Jeffrey L Saver
Journal:  N Engl J Med       Date:  2013-02-08       Impact factor: 91.245

10.  Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

Authors:  Joseph P Broderick; Yuko Y Palesch; Andrew M Demchuk; Sharon D Yeatts; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Frank L Silver; Rüdiger von Kummer; Carlos A Molina; Bart M Demaerschalk; Ronald Budzik; Wayne M Clark; Osama O Zaidat; Tim W Malisch; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Renée H Martin; Lydia D Foster; Thomas A Tomsick
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

View more
  3 in total

Review 1.  Achieving Multidisciplinary Collaboration for the Creation of a Pulmonary Embolism Response Team: Creating a "Team of Rivals".

Authors:  Christopher Kabrhel
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

Review 2.  Efficacy of stem cell-based therapies for stroke.

Authors:  Matthew R Chrostek; Emily G Fellows; Andrew T Crane; Andrew W Grande; Walter C Low
Journal:  Brain Res       Date:  2019-08-02       Impact factor: 3.252

3.  An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats.

Authors:  Jennifer F Iaci; Tom J Parry; Zhihong Huang; Elias Pavlopoulos; Seth P Finklestein; Jingmei Ren; Anthony Caggiano
Journal:  J Neurosci Res       Date:  2015-12-11       Impact factor: 4.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.